Swiss medical regulators have approved a new malaria treatment for infants, offering hope to many in Africa KAMPALA, Uganda - ...

Swiss regulators have approved the first malaria treatment safe for infants. The new drug, known as Coartem Baby or Riamet ...

A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled ...

The development of the new malaria medicine from the Basel-based pharmaceutical company Novartis for babies weighing 4½ to 11 pounds has given hope to many, with health workers in Nigeria, Congo and ...

Nigeria is among eight African countries to pioneer the rollout of the world’s first malaria treatment designed specifically ...

The Africa Centres for Disease Control and Prevention (Africa CDC) has welcomed the approval of the first malaria treatment ...

Malaria is caused by a parasite spread through mosquito bites. It’s preventable and treatable, but sickened 263 million people worldwide in 2023 and claimed nearly 600,000 lives, according to ...

Malaria parasites may be stopped in their tracks by a promising new group of compounds, suggests a new study in mice. The compounds may someday yield a new dual-action drug that targets both ...

Nigeria is among eight African countries to pioneer the rollout of the world’s first malaria treatment designed specifically ...

In search of new drug targets to overcome growing drug resistance, the researchers performed genomic and proteomic analyses of over 2000 P. falciparum samples from people infected with malaria, ...

The search for new ways to treat malaria—a disease that kills some 600,000 people a year, most of them children in Sub-Saharan Africa—may have just gotten a boost.

Hydroxychloroquine, a malaria drug President Donald Trump took to try to prevent COVID-19, proved ineffective for that in the first large, high-quality study to test it in health workers and ...